chr16-2071782-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000548.5(TSC2):c.1947-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000548.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC2 | NM_000548.5 | MANE Select | c.1947-2A>G | splice_acceptor intron | N/A | NP_000539.2 | |||
| TSC2 | NM_001406663.1 | c.1947-2A>G | splice_acceptor intron | N/A | NP_001393592.1 | ||||
| TSC2 | NM_001114382.3 | c.1947-2A>G | splice_acceptor intron | N/A | NP_001107854.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC2 | ENST00000219476.9 | TSL:5 MANE Select | c.1947-2A>G | splice_acceptor intron | N/A | ENSP00000219476.3 | |||
| TSC2 | ENST00000350773.9 | TSL:1 | c.1947-2A>G | splice_acceptor intron | N/A | ENSP00000344383.4 | |||
| TSC2 | ENST00000401874.7 | TSL:1 | c.1947-2A>G | splice_acceptor intron | N/A | ENSP00000384468.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1453754Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 722450
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1947-2A>G intronic pathogenic mutation results from an A to G substitution two nucleotides upstream from coding exon 18 in the TSC2 gene. This variant (also known as IVS17-2A>G in the literature) has been reported in multiple individuals with features consistent with tuberous sclerosis complex (Mayer K et al. Hum Mutat, 1999;14:401-11; Peron A et al. Eur J Med Genet, 2018 Jul;61:403-410; Ambry internal data). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data; Mayer K et al. Hum Mutat, 1999;14:401-11). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation.
Tuberous sclerosis syndrome Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at